STAAR Surgical Company
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a STAA research report →
Companywww.staar.com
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia; and Hyperopic ICL, which treats far-sightedness. It also offers preloaded silicone cataract intraocular lenses and injector systems for use in cataract surgery.
- CEO
- Warren Foust
- IPO
- 1992
- Employees
- 1,157
- HQ
- Lake Forest, CA, US
Price Chart
Valuation
- Market Cap
- $1.64B
- P/E
- -78.43
- P/S
- 5.64
- P/B
- 4.68
- EV/EBITDA
- 104.21
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 76.43%
- Op Margin
- -1.72%
- Net Margin
- -7.24%
- ROE
- -6.07%
- ROIC
- -1.26%
Growth & Income
- Revenue
- $239.44M · -23.72%
- Net Income
- $-80,448,000 · -298.10%
- EPS
- $-1.62 · -295.12%
- Op Income
- $-45,946,000
- FCF YoY
- -422.23%
Performance & Tape
- 52W High
- $35.87
- 52W Low
- $15.59
- 50D MA
- $23.61
- 200D MA
- $24.10
- Beta
- 1.20
- Avg Volume
- 1.31M
Get TickerSpark's AI analysis on STAA
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| May 15, 26 | ANDREWS DEBORAH J | other | 5,233 |
| May 15, 26 | ANDREWS DEBORAH J | other | 1,877 |
| May 15, 26 | ANDREWS DEBORAH J | other | 5,233 |
| May 15, 26 | ANDREWS DEBORAH J | other | 3,755 |
| May 15, 26 | ANDREWS DEBORAH J | other | 10,466 |
| May 15, 26 | ANDREWS DEBORAH J | other | 10,466 |
| May 15, 26 | Foust Warren | other | 7,331 |
| May 15, 26 | Foust Warren | other | 3,666 |
| May 15, 26 | Foust Warren | other | 1,865 |
| May 15, 26 | Foust Warren | other | 14,662 |
Our STAA Coverage
We haven't published any research on STAA yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate STAA Report →